VRTX 240823 477.50C (VRTX240823C477500) Stock Options, News & Quotes

US OptionsDetailed Quotes

VRTX240823C477500

Watchlist

5.80
+1.55+36.47%

15min DelayClose Aug 23 16:00 ET

5.80High5.80Low

Intraday

5D
Daily

News

Vertex to Participate in Upcoming September Investor Conferences
Vertex PharmaceuticalsAug 22 00:00 ET
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
BenzingaAug 21 12:30 ET
The AI Trade Is Over, BofA Says. What to Buy Instead.
BarronsAug 21 02:00 ET
Maxim Group Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating
Moomoo NewsAug 20 16:31 ET · Ratings
Vertex Pharmaceuticals: A Cautious Hold Amidst Mixed Financial Signals and Pipeline Uncertainty
TipRanksAug 20 15:35 ET · Ratings
Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
BenzingaAug 19 23:18 ET

Comments

EZ_money

Jun 17 18:58

Buying time

$SoFi Technologies (SOFI.US)$ 👈🤑🤤📈
$Vertex Pharmaceuticals (VRTX.US)$. $Citigroup (C.US)$

EZ_money: $SoFi Technologies (SOFI.US)$ home of the 2027 Super Bowl , NBA partnership, and World Soccer events...

ROM-STAR

May 16 04:48

Renaissance Technologies has completely sold out of their Google, Netflix, and Disney positions

The 13F filing for the hedge fund led by the late Jim Simons (RIP) just dropped and we got you covered
Here's a breakdown of the biggest moves:
🔴 SOLD (ranked by largest prev. portfolio %)
$Exxon Mobil (XOM.US)$ : 0.70%
$Boeing (BA.US)$ : 0.43%
$GE Aerospace (GE.US)$ : 0.41%
$Alphabet-C (GOOG.US)$ : 0.31%
$Netflix (NFLX.US)$ : 0.31%
$Disney (DIS.US)$ : 0.24%
🟢 NEW (ranked by portfolio %):
$Chevron (CVX.US)$ : 0.52%...

Meltyy

May 9 21:51

🚨 April-May 2024 M&A Highlights! 🚨

Keep an eye on these M&As: 👀
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt (ADTX.US)$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics (KTRA.US)$
$Johnson & Johnson (JNJ.US)$ to acquire $ShockWave Medical (SWAV.US)$
$Vertex Pharmaceuticals (VRTX.US)$ to acquire $Alpine Immune (ALPN.US)$
$Century Therapeutics (IPSC.US)$ to acquire Clade Tx
$Eliem Therapeutics (ELYM.US)$ to acquire Tenet Med.
$Incyte (INCY.US)$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals (DCPH.US)$
...

Shaaaw

May 8 05:01

No megadeals in biotech so far this yr, but on track for record amount >$1 bil deals,
2 biggest deals this yr:
$Vertex Pharmaceuticals (VRTX.US)$ paid $4.9 bil for $Alpine Immune (ALPN.US)$
$Gilead Sciences (GILD.US)$ paid $4.3 bil for $CBAY
Bolt-on deals likely to continue to be the dominant story in 2024, which means we could also see more of this trend...
Last yr 84% of M&A deal dollars were for Biotechs w/ Phase 3 & Marketed assets,
In the first four months of 2024 56% of M&A deal dollar went towards P...

Luzi Ann Santos

May 6 15:17

Columns Vertex Pharmaceuticals First Quarter Earnings, Revenue Beat Estimates

$Vertex Pharmaceuticals (VRTX.US)$ reported on May 6 first quarter adjusted earnings and revenue that beat analysts' estimates.
The company reported adjusted earnings of $4.76 a share on product revenue of $2.69 billion for the three months that ended March 31. Analysts estimates compiled by LSEG called for adjusted earnings of $4.06 per share and product revenue of $2.58 billion, according to Reuters.
The company kept its pr...

Editor's Picks: Community Q4 earnings insights & highlights